|Awarded On||June 18, 2010|
|Title||Medical Devices for the Treatment of Cancerous Lesions and the Gastrointestinal Tract|
|Program||Product Development Research|
|Award Mechanism||Company Commercialization|
|Principal Investigator/Program Director||Dennis McWilliams|
|Cancer Sites||Colorectal, Esophagus, Stomach|
Colorectal cancer is the third most commonly diagnosed cancer and the second most common cause of cancer death in the United States, while gastric cancer is the most common malignancy in the world. Each year, over 26 million individuals undergo screening colonoscopies to identify early stage colorectal cancer. However, once a suspicious lesion is found, physicians are limited in their ability to treat, and cancer surgery anywhere in the GI tract will leave a patient with a lifetime of digestive complications.
Apollo has developed a set of flexible surgical devices, compatible with existing flexible endoscopes, which enable a revolutionary new procedure to remove early stage lesions from t...